-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Vor Biopharma, Lowers Price Target to $32

Benzinga·11/14/2025 12:51:11
Listen to the news
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Vor Biopharma (NASDAQ:VOR) with a Buy and lowers the price target from $55 to $32.